Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Studied in peopleStub

TB-500

Thymosin beta-4 and its fragments

Thymosin beta-4 is a 43 amino acid protein that binds actin and is studied in wound and corneal healing. TB-500 is the name research suppliers use for it or for its active region.

Reconstitution calculator

At a glance

Studied in people

There are published studies in people. It is not a licensed medicine in the United States or the European Union.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies: TB-500

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

628
papers on PubMed
345
of them in people
3
randomized trials
70
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on TB-500 itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of TB-500; no amount here is a recommendation.

TB-500: on PubMed

What PubMed held for TB-500 on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

628
papers
345
in humans
4
clinical trials
3
randomized trials
2012: 24 papers122013: 22 papers2014: 20 papers142015: 25 papers2016: 28 papers162017: 25 papers2018: 20 papers182019: 21 papers2020: 18 papers202021: 27 papers2022: 13 papers222023: 17 papers2024: 12 papers242025: 18 papers2026: 22 papers so far26
Papers per year, 2012 to 2026. The most in one year: 28.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Logistic regression analysis of environmental and other variables and incidences of tuberculosis in respiratory patients

    TrialPathak AK, Sharma M, Katiyar SK, et al. Scientific reports, 2020. PMID 33318598

  2. Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing

    Randomized trialGuarnera G, DE Rosa A, Camerini R Annals of the New York Academy of Sciences, 2007. PMID 17495250

  3. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers

    Randomized trialRuff D, Crockford D, Girardi G, et al. Annals of the New York Academy of Sciences, 2010. PMID 20536472

  4. The effect of thymosin treatment of venous ulcers

    Randomized trialGuarnera G, DeRosa A, Camerini R, et al. Annals of the New York Academy of Sciences, 2010. PMID 20536470

  5. beta-Thymosins

    ReviewHannappel E Annals of the New York Academy of Sciences, 2007. PMID 17468232

  6. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

    ReviewMendias CL, Awan TM Sports medicine (Auckland, N.Z.), 2026. PMID 41966639

  7. Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids

    StudyZeng PM, Sun XY, Li Y, et al. Stem cell reports, 2025. PMID 40816274

  8. Thymosin β4 Promotes Dermal Healing

    ReviewKleinman HK, Sosne G Vitamins and hormones, 2016. PMID 27450738

Search used: ("thymosin beta-4"[tiab] OR "thymosin beta 4"[tiab] OR "TB-500"[tiab]). Run it on PubMed

Research links

Also in Repair and recovery

Sold in blends: BPC-157 + TB-500, BPC-157 + TB-500 + GHK-Cu, BPC-157 + TB-500 + GHK-Cu + KPV